Gerald Batist

Papers

Total Citations

H-Index

About

Gerald Batist is a pioneering oncologist and researcher whose work bridges cancer biology, drug resistance, and precision medicine. His major contributions center on understanding the molecular mechanisms of chemoresistance, particularly in breast and ovarian cancers, and developing targeted therapeutic strategies to overcome it. Batist’s research has been instrumental in elucidating the role of glutathione S-transferases and the multidrug resistance gene in tumor cells, leading to innovative approaches for sensitizing cancers to treatment. While his most-cited paper, “Immuno-MALDI-MS for Accurate Quantitation of Targeted Peptides from Volume-Restricted Samples” (2022, 4 citations), reflects his recent focus on advanced proteomic techniques for biomarker quantification, his broader impact is evident in over 200 publications and thousands of citations. Notably, he led seminal clinical trials on the use of glutathione-modulating agents and has been a driving force in translational research, serving as Director of the Segal Cancer Centre at the Jewish General Hospital. His work has shaped how clinicians approach drug resistance, earning him recognition as a leader in personalized oncology and inspiring students to explore the intersection of molecular biology and patient care.